Novugen Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOVUGEN, and what generic and branded alternatives to NOVUGEN drugs are available?
NOVUGEN has three approved drugs.
Drugs and US Patents for Novugen
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novugen | ABIRATERONE ACETATE | abiraterone acetate | TABLET;ORAL | 215947-002 | Jan 5, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novugen | SUNITINIB MALATE | sunitinib malate | CAPSULE;ORAL | 218012-003 | Aug 21, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novugen | SUNITINIB MALATE | sunitinib malate | CAPSULE;ORAL | 218012-002 | Aug 21, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novugen | ABIRATERONE ACETATE | abiraterone acetate | TABLET;ORAL | 215947-001 | Jan 5, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novugen | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 211973-002 | Oct 17, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novugen | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 211973-001 | Oct 17, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.